Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
Abstract Immune checkpoint inhibitor (ICI) treatments produce clinical benefit in many patients. However, better pretreatment predictive biomarkers for ICI are still needed to help match individual patients to the treatment most likely to be of benefit. Existing gene expression profiling (GEP)-based...
Main Authors: | Chuanliang Cui, Canqiang Xu, Wenxian Yang, Zhihong Chi, Xinan Sheng, Lu Si, Yihong Xie, Jinyu Yu, Shun Wang, Rongshan Yu, Jun Guo, Yan Kong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | npj Genomic Medicine |
Online Access: | https://doi.org/10.1038/s41525-021-00169-w |
Similar Items
-
Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images
by: Jing Hu, et al.
Published: (2021-01-01) -
Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
by: Baohui Hu, et al.
Published: (2020-11-01) -
Inconsistent prediction capability of ImmuneCells.Sig across different RNA-seq datasets
by: Xu Xiao, et al.
Published: (2021-07-01) -
Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.
by: David Wong, et al.
Published: (2012-01-01) -
Animal Models of Interferon Signature Positive Lupus
by: Haoyang eZhuang, et al.
Published: (2015-06-01)